Diabetes type 2, caused mainly by insulin resistance, is growing in incidence worldwide. In addition to being a major public health concern, type 2 diabetes is also a risk factor for dementia, including Alzheimer's disease type dementia. Coffee consumption is reported to have protective effects in both diabetes and Alzheimer's disease. We review here the reported beneficial effects of coffee in both disease conditions and the previously identified active ingredients of coffee. Furthermore, we revisit our recent findings of improved glucose utilization in the periphery and in the brain in a mouse model of high-fat diet induced type 2 diabetes after treatment with a decaffeinated green coffee preparation. Overall, consumption of coffee appears to improve diabetes and reduce the risk of dementia, although future studies are required to further identify the active components and the type of coffee that is most effective in addressing these conditions.
Introduction
Diabetes mellitus affected more than 371 million people globally in the year 2012 [1] and the incidence is rising every year. Approximately 90% of those affected are diagnosed with type 2 diabetes (T2DM), which is caused by insulin resistance, viz. defective insulin action or defects in insulin secretion [2, 3] . Several studies have reported the association of T2DM with increased risk of dementia, including Alzheimer's disease (AD) type dementia, and a recent meta-analysis of 15 epidemiological studies confirmed this association [4] . AD is the most common type of dementia and by the year 2025, it is projected that 7.1 million elderly people will be affected by AD, in the United States alone [5] .
Considering the high impact that these diseases have on public health, therapeutic or lifestyle interventions that are beneficial in both T2DM and AD would be invaluable.
Coffee is one of the most widely consumed beverages in the world. It is reported to have health benefits in many diseases, ranging from cancer to neurodegenerative disorders [6] .
Here we review the previously identified effects of coffee in T2DM and in AD, together with our finding of improved peripheral and brain glucose utilization in a mouse model of diabetes following treatment with a decaffeinated green coffee extract.
Health bene ts of co ee in diabetes
An inverse relationship between the amount of coffee consumed and the risk of developing T2DM was reported by two separate metaanalyses of population studies [7, 8] and in a systematic review of 13 previous studies [9] .
The consensus among studies from diverse populations was that more than 4 cups of coffee a day was the effective dose. There have also been a few reports that coffee has no effect on risk of T2DM [10, 11] .
Interestingly, a protective effect was also observed with decaffeinated coffee [12] [13] [14] , suggesting that non-caffeine components are involved in the anti-diabetic actions of coffee.
The potential use of decaffeinated coffee for diabetes prevention is also supported by studies showing that caffeine causes impaired glucose tolerance and decreased insulin sensitivity in people with T2DM [15] .
The mechanisms by which the various components of coffee protect against T2DM have been examined using several experimental systems (Table 1 ). The beneficial effect of caffeine on T2DM is proposed to act through increased expression of the uncoupling protein in brown adipose tissue and muscle [16] , leading to activation of resting metabolic rate [17] . Among the non-caffeine components, chlorogenic acid delays intestinal glucose absorption [18] , inhibits hepatic glucose-6-phosphatase [19] and increases muscle glucose uptake via increased expression of glucose transporter 4 and peroxisomal proliferatoractivated receptor γ [20] . Antioxidant activity is displayed by several coffee components.
Specifically, kahweol and cafestol act by decreasing reactive oxygen species generation, prevention of DNA damage, and increased removal of superoxide radicals [21] ; the major chlorogenic acid, 5-caffeoylquinic acid, reduces reactive oxygen species generation; and N-Methyl-2-methylpyridinium-iodide protects against DNA damage [22] .
Bene ts of co ee in Alzheimer's disease
Epidemiological studies showing that certain diets are associated with decreased risk of AD have led to increasing interest in the prevention of AD by dietary intervention [23] .
Coffee is one of the dietary components linked to a reduced risk of developing AD [24] [25] [26] .
Patients with mild cognitive impairment who had high levels of plasma caffeine had no progression to AD dementia over a 2-4 year study period, possibly via maintaining levels of the plasma cytokines granulocyte colonystimulating factor, interleukins -10 and -6 [27] . [31] . It also reduced amyloid pathology and cognitive deficits in mice expressing the amyloid precursor protein with the Swedish mutation [32] , by decreasing expression of presenilin 1 and β-secretase, enzymes needed for amyloid-β generation [33] . Caffeine serves as an antagonist of the adenosine receptors A 1 and A 2A [34, 35] ; these neurotransmitter receptors show altered distribution in the AD brain [36] and are being investigated as potential drug targets for AD. In a Caenorhabditis elegans model of amyloid-β toxicity, coffee, but not caffeine, showed protection mediated through the nuclear respiratory factor homolog [37] .
Nuclear respiratory factor is a transcription factor that regulates expression of genes related to mitochondrial metabolism [38] . Similar results were also found in a Drosophila model expressing amyloid-β and treated with decaffeinated coffee, with cafestol proposed as the active component [39] . Trigonelline, another coffee component, protected from the reduction in length of dendrites and axons in rat cortical neurons treated with amyloid-β, in vitro [40] .
Chlorogenic acid improved cognitive function in mice treated with scopolamine, a muscarinic acetylcholine receptor antagonist, to induce AD-like memory loss; it was shown to reverse the increased acetylcholinesterase activity and higher levels of the lipid peroxidation marker, malondialdehyde, that are characteristic of the model [41] . Chlorogenic acid also showed antioxidant properties in PC12 neuroblastoma cells treated with hydrogen peroxide to induce oxidative stress [42] .
Bene cial e ects of deca einated green co ee Svetol®. The high-fat diet was based on that previously described to cause insulin resistance in mice [44] and Svetol was administered in the drinking water at a concentration of 80 mg/kg body weight. Treatments were for 5 months, starting when the mice were 3 months of age.
We found that Svetol reversed the impaired glucose tolerance induced by high fat diet ( Figure 1A ), without any effect on weight gain in the high fat diet groups ( Figure 1B) . The mice on the various treatments had comparable food intake ( Figure 1C) Translational Neuroscience Table 2 ).
In conclusion, as summarized in Figure 3 
